Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mark Plavsic Insider Profile
4 Followers
Mark Plavsic, CTO at Fate Therapeutics, holds 121.13K shares in Aura Biosciences Inc (Ticker: AURA), holds 123.70K shares in Fate Therapeutics (Ticker: FATE). Most recently, Mark Plavsic Sold ― shares of Aura Biosciences Inc on Oct 16, 2024 for an estimated value of 72.72K.
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+39.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Mark Plavsic holds in companies
Most Profitable Insider Trade
The most profitable trade made by Mark Plavsic
Mark Plavsic's Trading History
Fate Therapeutics
Jan 11, 2023
CTO
Informative Sell
17.91K
$207.82K
Aura Biosciences Inc
Oct 16, 2024
Chief Technology Officer
Informative Sell
72.72K
$993.28K
List of latest transactions for each holding click on a transaction to see Mark Plavsic's performance on stock
You May Also Like
Mark Plavsic insider profile FAQ
What is the percentage of profitable transactions made by Mark Plavsic?
The percentage of profitable transactions made by Mark Plavsic is 100%.
What is the average return per transaction made by Mark Plavsic?
The average return per transaction made by Mark Plavsic is 39.40%.
What stocks does Mark Plavsic hold?
Mark Plavsic holds: FATE, AURA stocks.
What was Mark Plavsic’s latest transaction?
Mark Plavsic latest transaction was an Informative Sell of $72.72K.
What was Mark Plavsic's most profitable transaction?
Mark Plavsic’s most profitable transaction was an Informative Sell of FATE stock on July 6, 2022. The return on the trade was 83.60%.
What is Mark Plavsic's role in Fate Therapeutics?
Mark Plavsic's role in Fate Therapeutics is CTO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.